4 Results for "

ROCK2/STAT3

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ROCK2/STAT3" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-149266
CAS No.: 2226941-26-8
Purity:  99.80%
Target:  

ROCK

Research Areas:  

Cancer

THK01 is a potent ROCK2 inhibitor with IC50 values of 5.7 and 923 nM for ROCK2 and ROCK1, respectively. THK01 inhibits breast cancer metastasis through the ROCK2-STAT3 signaling pathway. THK01 can be used in research of breast cancer .
loading...
    loading...
Cat. No.: HY-178821
CAS No.: 3086603-12-2
Target:  

ROCK TGF-beta/Smad STAT

Research Areas:  

Inflammation/Immunology

ROCK2-IN-12 (Compound A25) is a selective ROCK2 inhibitor with an IC50 of 7.0  nM for ROCK2 over ROCK1. ROCK2-IN-12 has potent antifibrotic effects via the TGF-β/Smad and ROCK2/STAT3 signaling pathways. ROCK2-IN-12 significantly reduces collagen deposition and reverses fibrotic progression in Bleomycin (HY-108345)-induced pulmonary fibrosis (PF) mouse models. ROCK2-IN-12 can be used for lung diseases like pulmonary fibrosis research .
loading...
    loading...
Cat. No.: HY-175843
Target:  

ROCK STAT

Research Areas:  

Cancer

ROCK2-IN-10 is a potent and selective ROCK2 inhibitor (IC50 = 0.020 μM) with 41-fold selectivity over isoform ROCK1. ROCK2-IN-10 inhibits metastasis by disrupting the cytoskeleton, independent of proliferative suppression. ROCK2-IN-10 shows superior inhibitory potency against cancer cell metastasis, which closely related to the suppression of STAT3 phosphorylation. ROCK2-IN-10 can be used for breast cancer metastasis research .
loading...
    loading...
Cat. No.: HY-184149
Target:  

ROCK TGF-beta/Smad STAT

Research Areas:  

Inflammation/Immunology

ROCK2-IN-17 is an orally active and selective ROCK2 inhibitor with an IC50 of 8.1 nM. ROCK2-IN-17 achieves its antifibrotic effect by inhibiting the TGF-β/Smad and ROCK2/STAT3 signaling pathways. ROCK2-IN-17 can be used for pulmonary fibrosis research .
loading...
    loading...